Nutrien LTD.HARES (NYSE:NTR)’s Stock Is Buy After Less Market Selling

The stock of Nutrien LTD.HARES (NYSE:NTR) registered a decrease of 16.77% in short interest. NTR’s total short interest was 7.79M shares in September as published by FINRA. Its down 16.77% from 9.36M shares, reported previously. With 1.74 million shares average volume, it will take short sellers 5 days to cover their NTR’s short positions.

The stock increased 1.33% or $0.68 during the last trading session, reaching $51.78. About 470,233 shares traded. Nutrien Ltd. (NYSE:NTR) has risen 2.95% since September 10, 2018 and is uptrending. It has outperformed by 2.95% the S&P500.

Nutrien Ltd. produces and distributes potash, nitrogen, and phosphate products for agricultural, industrial, and feed clients worldwide. The company has market cap of $28.96 billion. It offers potash crop feed, fertilizer, industrial, metal finishing, and purified acid products, as well as blends. It has a 10.21 P/E ratio. The firm is also involved in the retail activities that serve growers in seven countries across three continents.

More notable recent Nutrien Ltd. (NYSE:NTR) news were published by: Fool.ca which released: “TFSA Investors: 2 Stocks to Buy and Hold Forever – The Motley Fool Canada” on August 17, 2019, also Seekingalpha.com with their article: “Nutrien To Acquire Ruralco For Australian Agribusiness Expansion – Seeking Alpha” published on March 06, 2019, Seekingalpha.com published: “Nutrien declares $0.43 dividend – Seeking Alpha” on November 05, 2018. More interesting news about Nutrien Ltd. (NYSE:NTR) were released by: Seekingalpha.com and their article: “Despite Poor Spring Weather Condition, We Like Nutrien’s Strong Growth Outlook – Seeking Alpha” published on June 10, 2019 as well as Benzinga.com‘s news article titled: “Citigroup Cuts Mosaic To Neutral, Says Phosphate Supply Outstrips Demand – Benzinga” with publication date: March 29, 2019.

Nutrien Ltd. (NYSE:NTR) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.